These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 10922131

  • 21. A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD.
    Donohue JF, Kalberg C, Emmett A, Merchant K, Knobil K.
    Treat Respir Med; 2004; 3(3):173-81. PubMed ID: 15219176
    [Abstract] [Full Text] [Related]

  • 22. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.
    Baraniuk J, Murray JJ, Nathan RA, Berger WE, Johnson M, Edwards LD, Srebro S, Rickard KA.
    Chest; 1999 Sep; 116(3):625-32. PubMed ID: 10492263
    [Abstract] [Full Text] [Related]

  • 23. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [Abstract] [Full Text] [Related]

  • 24. Assessment of the efficacy and safety of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler in patients with asthma.
    Chan R, Sousa AR, Mallett S, Hynds P, Homayoun-Valiani F, Tabberer M, Mehta R.
    Pulm Pharmacol Ther; 2016 Dec; 41():19-24. PubMed ID: 27599598
    [Abstract] [Full Text] [Related]

  • 25. Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers.
    Nelson HS, Chapman KR, Pyke SD, Johnson M, Pritchard JN.
    J Allergy Clin Immunol; 2003 Jul; 112(1):29-36. PubMed ID: 12847476
    [Abstract] [Full Text] [Related]

  • 26. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM, Boulet LP, Follows RM.
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [Abstract] [Full Text] [Related]

  • 27. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma.
    ZuWallack R, Adelglass J, Clifford DP, Duke SP, Wire PD, Faris M, Harding SM.
    Chest; 2000 Aug; 118(2):303-12. PubMed ID: 10936117
    [Abstract] [Full Text] [Related]

  • 28. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
    O'Connor RD, Nelson H, Borker R, Emmett A, Jhingran P, Rickard K, Dorinsky P.
    Pharmacoeconomics; 2004 Aug; 22(12):815-25. PubMed ID: 15294013
    [Abstract] [Full Text] [Related]

  • 29. Salmeterol/fluticasone propionate combination.
    Spencer CM, Jarvis B.
    Drugs; 1999 Jun; 57(6):933-40; discussion 941-3. PubMed ID: 10400406
    [Abstract] [Full Text] [Related]

  • 30. Inhaled salmeterol/fluticasone propionate: a review of its use in asthma.
    Reynolds NA, Lyseng-Williamson KA, Wiseman LR.
    Drugs; 2005 Jun; 65(12):1715-34. PubMed ID: 16060707
    [Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT, Mehta R, Chan RH, Despa SX, Louey MD.
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [Abstract] [Full Text] [Related]

  • 32. Salmeterol and fluticasone propionate given as a combination. Lack of systemic pharmacodynamic and pharmacokinetic interactions.
    Kirby S, Falcoz C, Daniel MJ, Milleri S, Squassante L, Ziviani L, Ventresca GP.
    Eur J Clin Pharmacol; 2001 Aug; 56(11):781-91. PubMed ID: 11294367
    [Abstract] [Full Text] [Related]

  • 33. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
    Rojas RA, Paluga I, Goldfrad CH, Duggan MT, Barnes N.
    J Asthma; 2007 Aug; 44(6):437-41. PubMed ID: 17654129
    [Abstract] [Full Text] [Related]

  • 34. Salmeterol/fluticasone propionate combination therapy 50/250 microg twice daily is more effective than budesonide 800 microg twice daily in treating moderate to severe asthma.
    Jenkins C, Woolcock AJ, Saarelainen P, Lundback B, James MH.
    Respir Med; 2000 Jul; 94(7):715-23. PubMed ID: 10926345
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of different inhaled combination therapies (EDICT): a randomised, double-blind comparison of Seretide (50/250 microg bd Diskus vs. formoterol (12 microg bd) and budesonide (800 microg bd) given concurrently (both via Turbuhaler) in patients with moderate-to-severe asthma.
    Ringdal N, Chuchalin A, Chovan L, Tudoric N, Maggi E, Whitehead PJ, EDICT Investigators.
    Respir Med; 2002 Nov; 96(11):851-61. PubMed ID: 12418582
    [Abstract] [Full Text] [Related]

  • 36. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 37. Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison.
    Boonsawat W, Goryachkina L, Jacques L, Frith L.
    Clin Drug Investig; 2008 Jul; 28(2):101-11. PubMed ID: 18211118
    [Abstract] [Full Text] [Related]

  • 38. Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment.
    Nelson HS, Wolfe JD, Gross G, Greos LS, Baitinger L, Scott C, Dorinsky P.
    Ann Allergy Asthma Immunol; 2003 Sep; 91(3):263-9. PubMed ID: 14533658
    [Abstract] [Full Text] [Related]

  • 39. Cost-effectiveness of salmeterol xinafoate/fluticasone propionate combination inhaler in chronic asthma.
    Doull I, Price D, Thomas M, Hawkins N, Stamuli E, Tabberer M, Gosden T, Rudge H.
    Curr Med Res Opin; 2007 May; 23(5):1147-59. PubMed ID: 17519082
    [Abstract] [Full Text] [Related]

  • 40. Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).
    Hoekx JC, Hedlin G, Pedersen W, Sorva R, Hollingworth K, Efthimiou J.
    Eur Respir J; 1996 Nov; 9(11):2263-72. PubMed ID: 8947070
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.